RNRihito Nagata

Rihito Nagata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rihito Nagata has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Nobuyuki Takemura

    Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan

    2 shared publications
  • Yoshifumi Beck

    Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan

    2 shared publications
  • Akifumi Kimura

    Department of Hepatobiliary and Pancreatic Surgery, Saitama Medical Center Saitama Medical University Kawagoe‐shi Japan

    1 shared publication
  • Akira Maki

    Department of Hepatobiliary and Pancreatic Surgery, Saitama Medical Center Saitama Medical University Kawagoe‐shi Japan

    1 shared publication
  • Akira Maki

    Hepatobiliary and Pediatric Surgery Division, Department of Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan

    1 shared publication
  • Hiroki Imada

    Department of Pathology, Saitama Medical Center Saitama Medical University Kawagoe‐shi Japan

    1 shared publication

Latest Publications

  • Open Access

    Salvage pancreaticoduodenectomy for localized recurrence after resection of ascending colon cancer: a case report

    by Rihito Nagata, Nobuyuki Takemura, Masahiko Komagome, Michio Kogure, Ryosuke Satake, Natsuko Takayanagi, Yasuhiro Nunokawa, Akira Maki, Yoshifumi Beck

    A 66-year-old man underwent right hemicolectomy for ascending colon cancer with direct invasion of gallbladder. Numerous aberrant proliferative vessels from the duodenum were noted. The pathological diagnosis was T4bN0M0, Stage IIC, with a KRAS G12D mutation. He received four cycles of adjuvant chemotherapy. Four months later, a mass approximately 3 cm in diameter involving the duodenum and ileum was identified and diagnosed as localized recurrence with no evidence of distant metastasis. After administration of two cycles of chemotherapy, contrast-enhanced computed tomography demonstrated tumor shrinkage. A pancreaticoduodenectomy was performed, including resection of the involved ileum, and the short segment of transverse colon. Pathological examination revealed adenocarcinoma proliferation extending across the adhesion plane between the duodenum and ileum, infiltrating the muscularis propria of both intestinal walls without intraluminal exposure. These findings suggested that the tumor originated from residual cancer cells at the dissection plane of the initial surgery. No postoperative adjuvant chemotherapy was administered, in accordance with the patient’s wishes. The patient has remained disease-free for more than 7 years after the pancreaticoduodenectomy.

  • A case of robotic distal pancreatectomy for solitary fibrous tumor of the pancreas

    by Rihito Nagata, Nobuyuki Takemura, Riki Ninomiya, Naganori Yamada, Shinichi Matsudaira, Akifumi Kimura, Natsuko Takayanagi, Hiroki Imada, Akira Maki, Yoshifumi Beck

    Solitary fibrous tumor (SFT) is a spindle cell tumor driven by the NAB2‐STAT6 fusion gene. While it can originate from any soft tissue, primary SFT of the pancreas is rare with limited reports. A 36‐year‐old man came to our department due to abdominal pain. Computed tomography revealed a circular mass with weak peripheral enhancement and an internal cyst in the pancreatic tail. Diagnosis was not confirmed through endoscopic ultrasound‐guided biopsy, and differential diagnoses included acinar cell carcinoma and pancreatic neuroendocrine tumor. A robotic distal pancreatectomy with splenectomy was performed, and the patient was discharged 11 days postoperatively. Histopathological examination showed an irregular arrangement of spindle cells, and immunohistochemical staining was positive for CD34 and STAT6, confirming an SFT diagnosis with low metastatic risk. Robotic surgery effectively managed this tumor.